Symbiotic Healthcare develops FMT pill for C. diff infection

Symbiotic Healthcare, based in Manhattan, N.Y., has developed a capsule containing the processed fecal matter used in the C. difficile treatment fecal microbiota transplantation, according to a Crain’s New York Business report.

Advertisement

Symbiotic Healthcare was founded by North Shore-LIJ Health System infectious disease specialist Bruce Hirsch, MD, and immunologist Gerard Honig. The company’s capsule holds the processed matter and can be refrigerated for later use.

In a preliminary test including 23 patients, the pills resulted in an 87 percent cure rate.

The company is currently self-funded, but its founders are looking for financial backing, according to the report.

More Articles on C. difficile:
NIH starats clinical trial for C. diff drug
8 things to know: FMT for C. diff infection safe in immunocompromised patients
Synthetic Biologics forms clinical advisory board for C. diff prevention product

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Clinical Leadership & Infection Control

Advertisement

Comments are closed.